These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30208929)

  • 1. PLD3 epigenetic changes in the hippocampus of Alzheimer's disease.
    Blanco-Luquin I; Altuna M; Sánchez-Ruiz de Gordoa J; Urdánoz-Casado A; Roldán M; Cámara M; Zelaya V; Erro ME; Echavarri C; Mendioroz M
    Clin Epigenetics; 2018 Sep; 10(1):116. PubMed ID: 30208929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRTC1 gene is differentially methylated in the human hippocampus in Alzheimer's disease.
    Mendioroz M; Celarain N; Altuna M; Sánchez-Ruiz de Gordoa J; Zelaya MV; Roldán M; Rubio I; Larumbe R; Erro ME; Méndez I; Echávarri C
    Alzheimers Res Ther; 2016 Apr; 8(1):15. PubMed ID: 27094739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.
    Cruchaga C; Karch CM; Jin SC; Benitez BA; Cai Y; Guerreiro R; Harari O; Norton J; Budde J; Bertelsen S; Jeng AT; Cooper B; Skorupa T; Carrell D; Levitch D; Hsu S; Choi J; Ryten M; Sassi C; Bras J; Gibbs RJ; Hernandez DG; Lupton MK; Powell J; Forabosco P; Ridge PG; Corcoran CD; Tschanz JT; Norton MC; Munger RG; Schmutz C; Leary M; Demirci FY; Bamne MN; Wang X; Lopez OL; Ganguli M; Medway C; Turton J; Lord J; Braae A; Barber I; Brown K; ; Pastor P; Lorenzo-Betancor O; Brkanac Z; Scott E; Topol E; Morgan K; Rogaeva E; Singleton A; Hardy J; Kamboh MI; George-Hyslop PS; Cairns N; Morris JC; Kauwe JSK; Goate AM
    Nature; 2014 Jan; 505(7484):550-554. PubMed ID: 24336208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLD3 in Alzheimer's disease.
    Wang J; Yu JT; Tan L
    Mol Neurobiol; 2015 Apr; 51(2):480-6. PubMed ID: 24935720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early epigenetic changes of Alzheimer's disease in the human hippocampus.
    Blanco-Luquin I; Acha B; Urdánoz-Casado A; Sánchez-Ruiz De Gordoa J; Vicuña-Urriza J; Roldán M; Labarga A; Zelaya MV; Cabello C; Méndez-López I; Mendioroz M
    Epigenetics; 2020 Oct; 15(10):1083-1092. PubMed ID: 32233750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TREM2 upregulation correlates with 5-hydroxymethycytosine enrichment in Alzheimer's disease hippocampus.
    Celarain N; Sánchez-Ruiz de Gordoa J; Zelaya MV; Roldán M; Larumbe R; Pulido L; Echavarri C; Mendioroz M
    Clin Epigenetics; 2016; 8():37. PubMed ID: 27051467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLD3 is a neuronal lysosomal phospholipase D associated with β-amyloid plaques and cognitive function in Alzheimer's disease.
    Nackenoff AG; Hohman TJ; Neuner SM; Akers CS; Weitzel NC; Shostak A; Ferguson SM; Mobley B; Bennett DA; Schneider JA; Jefferson AL; Kaczorowski CC; Schrag MS
    PLoS Genet; 2021 Apr; 17(4):e1009406. PubMed ID: 33830999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation signature of human hippocampus in Alzheimer's disease is linked to neurogenesis.
    Altuna M; Urdánoz-Casado A; Sánchez-Ruiz de Gordoa J; Zelaya MV; Labarga A; Lepesant JMJ; Roldán M; Blanco-Luquin I; Perdones Á; Larumbe R; Jericó I; Echavarri C; Méndez-López I; Di Stefano L; Mendioroz M
    Clin Epigenetics; 2019 Jun; 11(1):91. PubMed ID: 31217032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid Beta-Mediated Hypomethylation of Heme Oxygenase 1 Correlates with Cognitive Impairment in Alzheimer's Disease.
    Sung HY; Choi BO; Jeong JH; Kong KA; Hwang J; Ahn JH
    PLoS One; 2016; 11(4):e0153156. PubMed ID: 27058954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLD3 in Alzheimer's Disease: a Modest Effect as Revealed by Updated Association and Expression Analyses.
    Zhang DF; Fan Y; Wang D; Bi R; Zhang C; Fang Y; Yao YG
    Mol Neurobiol; 2016 Aug; 53(6):4034-4045. PubMed ID: 26189833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLD3 is accumulated on neuritic plaques in Alzheimer's disease brains.
    Satoh J; Kino Y; Yamamoto Y; Kawana N; Ishida T; Saito Y; Arima K
    Alzheimers Res Ther; 2014; 6(9):70. PubMed ID: 25478031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. V232M substitution restricts a distinct O-glycosylation of PLD3 and its neuroprotective function.
    Demirev AV; Song HL; Cho MH; Cho K; Peak JJ; Yoo HJ; Kim DH; Yoon SY
    Neurobiol Dis; 2019 Sep; 129():182-194. PubMed ID: 31121321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare Variants in PLD3 Increase Risk for Alzheimer's Disease in Han Chinese.
    Tan MS; Zhu JX; Cao XP; Yu JT; Tan L
    J Alzheimers Dis; 2018; 64(1):55-59. PubMed ID: 29865074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare Variants in PLD3 Do Not Affect Risk for Early-Onset Alzheimer Disease in a European Consortium Cohort.
    Cacace R; Van den Bossche T; Engelborghs S; Geerts N; Laureys A; Dillen L; Graff C; Thonberg H; Chiang HH; Pastor P; Ortega-Cubero S; Pastor MA; Diehl-Schmid J; Alexopoulos P; Benussi L; Ghidoni R; Binetti G; Nacmias B; Sorbi S; Sanchez-Valle R; Lladó A; Gelpi E; Almeida MR; Santana I; Tsolaki M; Koutroumani M; Clarimon J; Lleó A; Fortea J; de Mendonça A; Martins M; Borroni B; Padovani A; Matej R; Rohan Z; Vandenbulcke M; Vandenberghe R; De Deyn PP; Cras P; van der Zee J; Sleegers K; Van Broeckhoven C;
    Hum Mutat; 2015 Dec; 36(12):1226-35. PubMed ID: 26411346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Genome-Wide Analysis of DNA Methylation and Gene Expression in the Hippocampi of 5xFAD Alzheimer's Disease Mouse Model.
    Lee S; Lee HJ; Chun JM; Jung B; Kim J; Moon C; Kim C; Kim JS
    J Integr Neurosci; 2024 Jul; 23(7):138. PubMed ID: 39082299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The APOE Gene is Differentially Methylated in Alzheimer's Disease.
    Foraker J; Millard SP; Leong L; Thomson Z; Chen S; Keene CD; Bekris LM; Yu CE
    J Alzheimers Dis; 2015; 48(3):745-55. PubMed ID: 26402071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid protein-mediated differential DNA methylation status regulates gene expression in Alzheimer's disease model cell line.
    Sung HY; Choi EN; Ahn Jo S; Oh S; Ahn JH
    Biochem Biophys Res Commun; 2011 Nov; 414(4):700-5. PubMed ID: 22001921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid beta-mediated epigenetic alteration of insulin-like growth factor binding protein 3 controls cell survival in Alzheimer's disease.
    Sung HY; Choi EN; Lyu D; Mook-Jung I; Ahn JH
    PLoS One; 2014; 9(6):e99047. PubMed ID: 24964199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common Variants in PLD3 and Correlation to Amyloid-Related Phenotypes in Alzheimer's Disease.
    Wang C; Tan L; Wang HF; Yu WJ; Liu Y; Jiang T; Tan MS; Hao XK; Zhang DQ; Yu JT;
    J Alzheimers Dis; 2015; 46(2):491-5. PubMed ID: 26402410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation.
    Iwata A; Nagata K; Hatsuta H; Takuma H; Bundo M; Iwamoto K; Tamaoka A; Murayama S; Saido T; Tsuji S
    Hum Mol Genet; 2014 Feb; 23(3):648-56. PubMed ID: 24101602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.